Mpm Bioimpact Llc
Source: SEC Form 13F · as of Mar 2026Mpm Bioimpact Llc holds 22 biotech & pharma companies tracked by BioSniper, totaling $691.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$691.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Cullinan Therapeutics, Inc. (CGEM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| CGEMCullinan Therapeutics, Inc. | 7,648,268 | $108.7M |
| LQDALiquidia Corp | 1,405,158 | $53.0M |
| ALMSALUMIS INC. | 2,386,529 | $52.6M |
| RVMDREVOLUTION MEDICINES, INC. | 506,776 | $49.3M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 1,306,261 | $44.2M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 423,982 | $35.6M |
| MLTXMoonLake Immunotherapeutics | 1,811,082 | $33.8M |
| TVTXTravere Therapeutics, Inc. | 1,133,365 | $33.7M |
| CYTKCYTOKINETICS INC | 500,000 | $33.0M |
| CNTXContext Therapeutics Inc. | 10,679,391 | $28.0M |
| FBRXForte Biosciences, Inc. | 1,000,682 | $25.9M |
| PVLAPALVELLA THERAPEUTICS, INC. | 206,404 | $25.7M |
| STOKStoke Therapeutics, Inc. | 767,038 | $25.0M |
| RLAYRelay Therapeutics, Inc. | 2,359,586 | $23.5M |
| ORICOric Pharmaceuticals, Inc. | 1,803,945 | $22.9M |
| QUREuniQure N.V. | 1,369,231 | $22.4M |
| CLYMClimb Bio, Inc. | 2,593,439 | $17.8M |
| ARQTArcutis Biotherapeutics, Inc. | 733,966 | $17.3M |
| ZYMEZymeworks Inc. | 565,249 | $14.2M |
| VRDNViridian Therapeutics, Inc.\DE | 649,873 | $12.7M |
| ABVXAbivax SA | 107,268 | $11.9M |
| HOWLWerewolf Therapeutics, Inc. | 1,208,810 | $1.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.